CERS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CERS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cerus has the Financial Strength Rank of 3. It displays poor financial strength and is likely in financial distress. Usually this is caused by too much debt for the company.
Warning Sign:
Cerus Corp displays poor financial strength. Usually, this is caused by too much debt for the company.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.
Cerus did not have earnings to cover the interest expense. Cerus's debt to revenue ratio for the quarter that ended in Mar. 2025 was 0.57. As of today, Cerus's Altman Z-Score is -4.82.
For the Medical Devices subindustry, Cerus's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Cerus's Financial Strength distribution charts can be found below:
* The bar in red indicates where Cerus's Financial Strength falls into.
GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Cerus's Interest Expense for the months ended in Mar. 2025 was $-2.1 Mil. Its Operating Income for the months ended in Mar. 2025 was $-5.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was $76.8 Mil.
Cerus's Interest Coverage for the quarter that ended in Mar. 2025 is
Cerus did not have earnings to cover the interest expense. |
The higher the ratio, the stronger the company's financial strength is.
2. Debt to revenue ratio. The lower, the better.
Cerus's Debt to Revenue Ratio for the quarter that ended in Mar. 2025 is
Debt to Revenue Ratio | = | Total Debt (Q: Mar. 2025 ) | / | Revenue | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Revenue | |
= | (22.629 | + | 76.817) | / | 172.956 | |
= | 0.57 |
3. Altman Z-Score.
Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
The zones of discrimination were as such:
When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.
Cerus has a Z-score of -4.82, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.
Warning Sign:
Altman Z-score of -4.82 is in distress zone. This implies bankruptcy possibility in the next two years.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cerus (NAS:CERS) Financial Strength Explanation
The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.
Cerus has the Financial Strength Rank of 3. It displays poor financial strength and is likely in financial distress. Usually this is caused by too much debt for the company.
Thank you for viewing the detailed overview of Cerus's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.
Chrystal Menard | officer: Chief Legal Officer | C/O CERUS CORPORATION, 2550 STANWELL DRIVE, CONCORD CA 94520 |
Kevin Dennis Green | officer: Chief Accounting Officer | C/O CERUS CORPORATION, 2411 STANWELL DRIVE, CONCORD CA 94520 |
Richard J Benjamin | officer: Chief Medical Officer | 15 WHITE PINE ROAD, NEWTON MA 02464 |
Vivek K Jayaraman | officer: Chief Commercial Officer | 3910 BRICKWAY BLVD, SANTA ROSA CA 95403 |
William Mariner Greenman | officer: President, Cerus Europe | C/O CERUS CORPORATION, 2411 STANWELL DRIVE, CONCORD CA 94520 |
Eric Bjerkholt | director | 132 PURDURE AVENUE, KENGSINGTON CA 94708 |
Hua Shan | director | C/O CERUS CORPORATION, 1220 CONCORD AVE., STE. 600, CONCORD CA 94520 |
Jami K Nachtsheim | director | |
Frank Witney | director | 940 WINTER STREET, C/O PERKINELMER, WALTHAM MA 02451 |
Swisher Daniel N Jr | director | C/O SUNESIS PHARMACEUTICALS, INC., 395 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO CA 94080 |
Laurence M Corash | director | C/O CERUS CORP, 2411 STENWELL DRIVE, CONCORD CA 94520 |
Carol Moore | officer: SR. V.P. Regulatory, Clinical | C/O CERUS CORPORATION, 2550 STANWELL DRIVE, CONCORD CA 94520 |
Ann Lucena | director | C/O CERUS CORPORATION, 1220 CONCORD AVE. SUITE 600, CONCORD CA 94520 |
Gail Schulze | director | 3451 WELLS ROAD, MALVERN PA 19355 |
Timothy B Anderson | director | C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015 |
From GuruFocus
By GuruFocus News • 11-13-2024
By Business Wire • 02-19-2025
By GuruFocus News • 02-21-2025
By GuruFocus News • 02-21-2025
By GuruFocus News • 02-20-2025
By GuruFocus News • 10-29-2024
By GuruFocus News • 05-29-2025
By GuruFocus News • 10-31-2024
By GuruFocus News • 05-28-2025
By GuruFocus News • 04-17-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.